Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Launched by UNIVERSITY OF CHICAGO · Jan 8, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how providing education about a specific surgical option, called orchiectomy (which is the removal of the testicles), can help men with prostate cancer make better treatment decisions. The trial focuses on patients who are already receiving long-term hormone treatment for prostate cancer and want to learn more about their options. By understanding the benefits and risks of orchiectomy compared to ongoing hormone therapy, the researchers want to see if more patients would consider this surgery as an alternative.

To participate in this study, individuals must be diagnosed with advanced prostate cancer, have been on hormone treatment for at least one year, and be able to complete surveys in English. The study is open to all men aged 65 to 74. If you join the trial, you'll receive information about orchiectomy and share your thoughts through surveys. This research aims to improve how patients understand their treatment choices and ultimately help them make informed decisions about their care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of metastatic prostatic adenocarcinoma
• • Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy
• • Able to complete written surveys in English
• Exclusion Criteria:
• • More than 2 prior systemic treatment regimens utilized in addition to castration.